Clinical Trials Browser

Phase 1/2 × Hemorrhage × Lymphoid × Clear all

NCT05672420 2023-01-05

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Phase 1/2 Unknown

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Hemorrhage, Infections, Leukemia, Lymphoma, Multiple Myeloma, Neutropenia, Thrombocytopenia, Hematologic Neoplasms